Replies to post #106478 on Anavex Life Sciences Corp (AVXL)

[falconer66a]

Those who need to know, know.

I thank several posters for their commendations of my descriptions of the efficacy and safety of Anavex technologies (proprietary molecules) for the eventual successful treatment of neurodegenerative diseases. I'm honored to be able to helpfully tell the powerful Anavex story here. I have rather extensive science writing experiences, and I'm a retired advance-placement biology teacher. I understand the fundamentals of the otherwise complex biochemistry of Anavex drugs, and, to a degree, can explain them to interested audiences.

Importantly, none of the arcane cellular and chemical processes of the Anavex drugs are hidden, mysterious, or un-comprehended by those who need to know. Of course, all of the Anavex principals know the details. But, so now do FDA and potential pharmaceutical collaborators and support groups. All of this may continue to be mystical to common retail equity buyers, institutional buyers, and financial advisors. But none of them will play any roles in Anavex's future successes. Those who know the story will guide its successful conclusion.